α-Lipoic acid attenuates coxsackievirus B3-induced ectopic calcification in heart, pancreas, and lung

Biochemical and Biophysical Research Communications

Volumn 432, Issue 2, 2013, Pages 378-383

  Kim, Hyo Shin ^a,d   Shin, Hong In ^b   Lim, Hyun Sook ^c   Lee, Tae Yoon ^d   Lee, Kyunghee ^d   Jeong, Daewon ^d  

^a TaeKyeung University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Hanyang Women's University   (South Korea)

^d Yeungnam University College of Medicine   (South Korea)

Author keywords

Lipoic acid; Coxsackievirus B3; Ectopic calcification; Osteogenic signal

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; OSTEONECTIN; OSTEOPONTIN; THIOCTIC ACID; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CALCIFICATION; CELL DEATH; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DRUG EFFECT; GENE INDUCTION; HEART INJURY; LUNG INJURY; MALE; MOUSE; NONHUMAN; PANCREAS INJURY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CALCINOSIS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; FEMALE; HEART; HUMANS; LUNG; MALE; MICE; PANCREAS; THIOCTIC ACID;

COXSACKIEVIRUS; MUS;

EID: 84875276699     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.061     Document Type: Article

References (28)

1. Murshed M., McKee M.D. Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr. Opin. Nephrol. Hypertens. 2010, 19:359-365.
2. Chan E.D., Morales D.V., Welsh C.H., McDermott M.T., Schwarz M.I. Calcium deposition with or without bone formation in the lung. Am. J. Respir. Crit. Care Med. 2002, 165:1654-1669.
3. Fadini G.P., Albiero M., Menegazzo L., Boscaro E., Vigili de Kreutzenberg S., Agostini C., Cabrelle A., Binotto G., Rattazzi M., Bertacco E., Bertorelle R., Biasini L., Mion M., Plebani M., Ceolotto G., Angelini A., Castellani C., Menegolo M., Grego F., Dimmeler S., Seeger F., Zeiher A., Tiengo A., Avogaro A. Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ. Res. 2011, 108:1112-1121.
4. Schoppet M., Shroff R.C., Hofbauer L.C., Shanahan C.M. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating?. Kidney Int. 2008, 73:384-390.
5. Karwowski W., Naumnik B., Szczepanski M., Mysliwiec M. The mechanism of vascular calcification-a systematic review. Med. Sci. Monit. 2012, 18:RA1-11.
6. Oka K., Oohira K., Yatabe Y., Tanaka T., Kurano K., Kosugi R., Murata M., Hakozaki H., Nishikawa T., Tsutsumi Y. Fulminant myocarditis demonstrating uncommon morphology-a report of two autopsy cases. Virchows Arch. 2005, 446:259-264.
7. Proudfoot D., Skepper J.N., Hegyi L., Bennett M.R., Shanahan C.M., Weissberg P.L. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ. Res. 2000, 87:1055-1062.
8. Steitz S.A., Speer M.Y., Curinga G., Yang H.Y., Haynes P., Aebersold R., Schinke T., Karsenty G., Giachelli C.M. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ. Res. 2001, 89:1147-1154.
9. Sun Y., Byon C.H., Yuan K., Chen J., Mao X., Heath J.M., Javed A., Zhang K., Anderson P.G., Chen Y. Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ. Res. 2012, 111:543-552.
10. Luo G., Ducy P., McKee M.D., Pinero G.J., Loyer E., Behringer R.R., Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386:78-81.
11. Neven E., D'Haese P.C. Vascular calcification in chronic renal failure: what have we learned from animal studies?. Circ. Res. 2011, 108:249-264.
12. Hsu J.J., Tintut Y., Demer L.L. Murine models of atherosclerotic calcification. Curr. Drug Targets 2008, 9:224-228.
13. Atkinson J. Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences. J. Appl. Physiol. 2008, 105:1643-1651.
14. Lee K., Kim H., Park H.S., Kim K.-J., Song H., Shin H.-I., Kim H.-S., Seo D., Kook H., Ko J.-H., Jeong D. Targeting of the osteoclastogenic RANKL-RANK axis prevents osteoporotic bone loss and soft tissue calcification in coxsackievirus B3-infected mice. J. Immunol. 2013, 190:1623-1630.
15. Li X., Yang H.Y., Giachelli C.M. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ. Res. 2006, 98:905-912.
16. Kim H., Kim H.J., Lee K., Kim J.M., Kim H.S., Kim J.R., Ha C.M., Choi Y.K., Lee S.J., Kim J.Y., Harris R.A., Jeong D., Lee I.K. Alpha-lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. J. Cell. Mol. Med. 2012, 16:273-286.
17. Byon C.H., Javed A., Dai Q., Kappes J.C., Clemens T.L., Darley-Usmar V.M., McDonald J.M., Chen Y. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J. Biol. Chem. 2008, 283:15319-15327.
18. Hsu J.J., Tintut Y., Demer L.L. Vitamin D and osteogenic differentiation in the arterywall. Clin. J. Am. Soc. Nephrol. 2008, 3:1542-1547.
19. Tintut Y., Patel J., Parhami F., Demer L.L. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000, 102:2636-2642.
20. Shao J.S., Cheng S.L., Sadhu J., Towler D.A. Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 2010, 55:579-592.
21. Lau W.L., Leaf E.M., Hu M.C., Takeno M.M., Kuro O.M., Moe O.W., Giachelli C.M. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int. 2012, 82:1261-1270.
22. Price P.A., June H.H., Buckley J.R., Williamson M.K. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler., Thromb., Vasc. Biol. 2001, 21:1610-1616.
23. Heiss A., Eckert T., Aretz A., Richtering W., van Dorp W., Schafer C., Jahnen-Dechent W. Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J. Biol. Chem. 2008, 283:14815-14825.
24. Hofbauer L.C., Brueck C.C., Shanahan C.M., Schoppet M., Dobnig H. Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos. Int. 2007, 18:251-259.
25. Hagen T.M., Liu J., Lykkesfeldt J., Wehr C.M., Ingersoll R.T., Vinarsky V., Bartholomew J.C., Ames B.N. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc. Natl. Acad. Sci. USA 2002, 99:1870-1875.
26. Shay K.P., Moreau R.F., Smith E.J., Smith A.R., Hagen T.M. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta 2009, 1790:1149-1160.
27. Ghibu S., Richard C., Vergely C., Zeller M., Cottin Y., Rochette L. Antioxidant properties of an endogenous thiol: alpha-lipoic acid, useful in the prevention of cardiovascular diseases. J. Cardiovasc.Pharmacol. 2009, 54:391-398.
28. Smith A.R., Shenvi S.V., Widlansky M., Suh J.H., Hagen T.M. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem. 2004, 11:1135-1146.